Tel: +44(0)20 7691 0984 Email: contact@transpharmation.co.uk Newsletter Sign Up
  • CEO Mark Duxon interviewed by The Pharma Letter on impact of Brexit on CROs...
  • Announcing new premises in Poland with a focus on neuropsychiatric disorders...
  • State-of-the-art premises opening this month at Discovery Park in Kent...
  • Newly published work in Frontiers in Psychiatry demonstrating
  • the effectiveness of a clinically relevant dose of ketamine...
  • Head to 2021 conferences page to see titles of abstracts...
 

Conferences

All the latest conference updates; those that we are attending and the studies that we are presenting

The Neuroimmunology Drug Development Summit is the industry’s definitive and unrivalled forum focused on pushing the frontiers of targeting neuroinflammation for CNS Indications. Transpharmation would be joining the 80+ neuroimmunology drug development experts to present a poster on our new neuroinflammation models, as well as to learn from those pioneering the field, network and build meaningful future partnerships. To discover more about our Neuroimmunology & Neuroinflammation capabilities, please get in touch with us via https://www.transpharmation.co.uk/contact.

 

Start a Conversation

uk flag+44 (0)20 7691 0984

ireland flag+353 (0)1896 42 60

poland flag+48 515 244 120

mail contact@transpharmation.co.uk


Copyright

Copyright © 2021 Transpharmation Ltd. All Rights Reserved.

Copyright © 2019 Transpharmation Ltd. All Rights Reserved. Website created by Identity Ipswich Web Design